Prenetics Global (PRE) EBITDA Margin (2021 - 2026)
Prenetics Global (PRE) posted quarterly EBITDA Margin of 15.57% for Q1 2026, up 1390.0% year-over-year from 1.05% in Q1 2025, and down 182.34% quarter-over-quarter from 5.52% in Q4 2025.
Prenetics Global (PRE) EBITDA Margin (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported EBITDA Margin for 6 consecutive years, with 15.57% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 1390.0% year-over-year to 15.57%; the TTM figure through Mar 2026 stood at 21.42% (up 14472.0% YoY), while the FY2025 annual figure was 48.14%, up 17946.0% from the prior year.
- EBITDA Margin declined to 15.57% in Q1 2026 per PRE's latest filing, from 5.52% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1446.56% in Q2 2024 and bottomed at 396.18% in Q3 2022.
- Historically, EBITDA Margin has averaged 8.45% across 5 years, with a median of 56.93% in 2025.
- Annual changes were most pronounced in 2024 — EBITDA Margin jumped 167463 bps — and 2025, when it plunged 150349 bps.
- Prenetics Global's EBITDA Margin stood at 426.08% in 2022, then plunged by 166 bps to 283.17% in 2023, then surged by 49 bps to 143.44% in 2024, then jumped by 96 bps to 5.52% in 2025, then plunged by 182 bps to 15.57% in 2026.
- Business Quant data shows PRE's EBITDA Margin at 15.57% in Q1 2026, 5.52% in Q4 2025, and 26.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Prenetics Global | 306.55 Mn | 200.52 Mn | 23.28 Mn | -15.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.57% |
| Dec 31, 2025 | -5.52% |
| Sep 30, 2025 | -26.17% |
| Jun 30, 2025 | -56.93% |
| Mar 31, 2025 | -29.47% |
| Dec 31, 2024 | -143.44% |
| Sep 30, 2024 | -269.76% |
| Jun 30, 2024 | 1,446.56% |
| Mar 31, 2024 | -64.03% |
| Dec 31, 2023 | -283.17% |
| Sep 30, 2023 | -265.29% |
| Jun 30, 2023 | -228.07% |
| Mar 31, 2023 | -115.55% |
| Dec 31, 2022 | 426.08% |
| Sep 30, 2022 | -396.18% |
| Jun 30, 2022 | 156.40% |
| Mar 31, 2022 | 13.81% |
| Dec 31, 2021 | -9.12% |
| Sep 30, 2021 | -7.15% |
| Jun 30, 2021 | 25.45% |